Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
スポンサーリンク
概要
- 論文の詳細を見る
CByB6F1-Tg (HRAS) 2Jic mice (brand name: rasH2 mouse) are produced by two breeding facilities, CLEA Japan, Inc. (Fuji, Shizuoka, Japan) and Taconic (Germantown, NY, USA), and supplied world wide. To confirm carcinogenic conformity of both mice, a 26-week carcinogenicity test was performed on a total of 120 mice obtained from both facilities under the same protocol and same timing in our facility. All mice were divided into a vehicle (citrate buffer at pH4.5, 10ml/kg, single intraperitoneal injection) group and a MNU (N-methyl-N-nitrosourea, 75mg/kg, single intraperitoneal injection) group. Fifteen mice of each sex were assigned to each group. The survival rate of the vehicle group was maintained at 100% for mice from both facilities at completion of the test. In the MNU group, MNU-induced tumor death occurred from 9 to 12 weeks after administration, and the final survival rate for both facilities was 6.7%. In the pathological examination, only benign tumors of lungs, spleen, forestomach and skin were observed in a few mice in the vehicle group of both facilities. In the MNU group, the incidence of forestomach papilloma/squamous cell carcinoma in mice from both facilities was 100%. The incidences of malignant lymphoma in CLEA Japan mice and Taconic mice were 86.7% and 93.3%, respectively, and no significant difference was observed (Fisher's exact probability test). Although lung adenoma and skin papilloma/keratoacanthoma, which are major MNU induced tumors in this strain, were observed in several mice from both facilities, no significant differences were found. Consequently, carcinogenic conformity of rasH2 mice derived from two breeding facilities was confimled by the present study.
- 日本トキシコロジー学会の論文
- 2008-10-01
著者
-
Nomura Tatsuji
Central Institute For Experimental Animals
-
YOSHIMURA Masumi
Central Institute for Experimental Animals
-
Tsutsumi Hideki
Central Institute For Experimental Animals
-
Machida Kazuhiko
Central Institute for Experimental Animals
-
Urano Koji
Central Institute for Experimental Animals
-
Usui Toshimi
Central Institute for Experimental Animals
-
Urano Kouji
Central Institute For Experimental Animals
-
Machida Kazuhiko
The Department Of Pathology Nippon Experimental Medical Research Institute Co. Ltd
関連論文
- ラット大腸における異常陰窩巣形成ならびにrasH2マウスにおける大腸発癌に対するヨーグルトの抑制効果
- Decontamination of Human Xenotransplantable Tumor with Mouse Hepatitis Virus by Implantation in Nude Rat: A Case Report
- Quarantine for Contaminated Pathogens in Transplantable Human Tumors or Infections in Tumor Bearing Mice
- Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
- Chemotherapeutic Profiles of Human Tumors Implanted in SCID Mice Showing Appreciable Inconsistencies with Those in Nude Mice
- "C-7 A Rapid Carcinogenicity Test in Transgenic Mice Carrying Human c-Ha-ras Gene.
- The in vivo development of human T cells from CD34^+ cells in the murine thymic environment
- EXAMINATION OF PERCUTANEOUS APPLICATION IN A 26-WEEK CARCINOGENICITY TEST IN CB6F1-TG rasH2 MICE
- A rapid carcinogenicity testing system using transgenic mice harboring human prototype c-Ha-ras gene
- Induction of Drug Metabolism-Related Enzymes by Methylcholanthrene and Phenobarbital in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene and Their Wild Type Littermates
- ANALYSIS OF ABNORMALITY OF CORTICOHISTOGENESIS IN THE REELER MUTANT MICE BY PRODUCING CHIMERA MICE : ABSENCE OF ABNORMALITY IN NEURONS IN THE REELER (Contribution of Histochemistry to Developmental Neurobiology)
- A Humanized anti-c-erbB-2 Monoclonal Antibody for the Treatment of Breast Cancer
- Use of IC tags in short-term carcinogenicity studies on CB6F1-TgrasH2 mice(Carcinogenicity, Proceedings of the 32nd Annual Meeting)
- P8-31 Effect of vehicles for a dermal carcinogenicity testing of CB6F1-TgrasH2 mice(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-41 Comparative study on the carcinogenicity of phenolphthalein in rasH2 and p53 knockout mice(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Influence of the administration route and the vehicle on CB6F1-TgrasH2 mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Background data of human prototype c-Ha-ras transgenic (CB6Fl-TgrasH2) mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Biological characteristics of gene-manipulated mice for carcinogenicity test (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- USE OF IC TAGS IN SHORT-TERM CARCINOGENICITY STUDY ON CB6F1 TGrasH2 MICE
- C57BL/6JJclを遺伝的背景に持つIRS2欠損マウスの効率的な繁殖方法の検討
- Inhibitory Effect of Apple Pectin and Culture Condensate of Bifidobacterium Iongum of Colorectal Tumors Induced by 1,2-Dimethylhydrazine in Transgenic Mice Harboring Human Prototype c-Ha-ras Genes
- Effect of Mouse Intestinal Bacteria on Incidence of Colorectal Tumors Induced by 1, 2-dimethylhydrazine Injection in Gnotobiotic Transgenic Mice Harboring Human Prototype c-Ha-ras Genes
- Conversion of the Genetic Background of Transgenic Mice by In Vitro Fertilization
- The Creation of Mouse Models for Human Diseases Associated with Reproductive Disturbances by In Vitro Fertilization and Embryo Transfer
- P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting)
- 22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.
- 21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity.
- P-46 Differences in immunotoxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 weeks.(Proceedings of the 27th Annual Meeting)
- Report 1 : TESTING FOR CARCINOGENICITY OF PHARMACEUTICALS : S1, A ; Conditions which require carcinogenicity studies for pharmaceuticals S1, B ; Use of two rodent species S1, C ; Dose selection for carcinogenicity studies of pharmaceuticals (CA
- Acute neurotoxicity study in rats given a single oral administration of Trimethyltin chloride and Acrylamide.(GENERAL SESSION BY POSTER PRESENTATION)(NERVOUS SYSTEM)
- The analysis of locomotor activity of male and female rats in functional observation buttery (FOB) in neurotoxicity study.(GENERAL SESSION BY POSTER PRESENTATION)(NERVOUS SYSTEM)
- Higher susceptibility of NOG mice to xenotransplanted tumors
- Aberrant Expression of Cyclin D1 in Pulmonary Proliferative Lesions Induced by High Doses of Urethane in Transgenic Mice Carrying the Human Prototype c-H-ras Gene
- Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
- HETEROTRANSPLANTATION OF HUMAN NEOPLASMS IN NUDE MICE
- MONOASSOCIATION WITH BACTERIA IN THE INTESTINES OF GERMFREE MICE